Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) — Tangible Net Worth Ratio
Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) has a Tangible Net Worth Ratio of 96.9% as of September 2025. This metric is calculated by deducting intangible assets (CN¥35.48 Million) from net assets (CN¥1.15 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Suzhou Zelgen Biopharmaceuticals Co Ltd net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Suzhou Zelgen Biopharmaceuticals Co Ltd Tangible Net Worth Ratio (2016–2024)
This chart shows how Suzhou Zelgen Biopharmaceuticals Co Ltd's Tangible Net Worth Ratio has changed across 9 annual periods from 2016 to 2024. As of September 2025, the ratio stands at 96.9%, reflecting net assets of CN¥1.15 Billion with intangible assets of CN¥35.48 Million CNY. Also explore Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Suzhou Zelgen Biopharmaceuticals Co Ltd (2016–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Suzhou Zelgen Biopharmaceuticals Co Ltd from 2016 to 2024, covering 9 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Suzhou Zelgen Biopharmaceuticals Co Ltd market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 96.0% | CN¥1.25 Billion | CN¥50.01 Million | CN¥3.00 Billion | ▲ +0.2 pp |
| 2023 | 95.8% | CN¥1.64 Billion | CN¥69.27 Million | CN¥2.89 Billion | ▲ +7.3 pp |
| 2022 | 88.4% | CN¥787.49 Million | CN¥91.03 Million | CN¥1.67 Billion | ▼ -2.3 pp |
| 2021 | 90.7% | CN¥1.25 Billion | CN¥116.29 Million | CN¥1.75 Billion | ▼ -1.6 pp |
| 2020 | 92.3% | CN¥1.69 Billion | CN¥129.51 Million | CN¥1.97 Billion | ▲ +176.5 pp |
| 2019 | -84.1% | CN¥73.75 Million | CN¥135.81 Million | CN¥320.27 Million | ▼ -128.6 pp |
| 2018 | 44.5% | CN¥281.64 Million | CN¥156.43 Million | CN¥454.88 Million | ▼ -38.0 pp |
| 2017 | 82.4% | CN¥73.02 Million | CN¥12.84 Million | CN¥147.63 Million | ▼ -5.6 pp |
| 2016 | 88.0% | CN¥109.44 Million | CN¥13.15 Million | CN¥137.20 Million | — |